GPT Healthcare Q1FY27: Profit up 66%, revenue 18%

Key takeaway from the June-quarter print

GPT Healthcare Limited reported a sharp year-on-year improvement in profitability for the quarter ended June 30, 2026 (Q1FY27), supported by a double-digit rise in revenue from operations. Net profit after tax rose to ₹12.73 crore, while revenue from operations increased to ₹126.20 crore, indicating stronger operating performance in its healthcare services business. The company’s board approved the unaudited results on August 3, 2026, at a meeting held in Kolkata. The financial statements were subject to a limited review by statutory auditors S.R. Batliboi & Co. LLP. The auditors issued an unmodified conclusion under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

What the company reported for Q1FY27

For Q1FY27, GPT Healthcare posted net profit after tax of ₹12.73 crore, up 65.9% from ₹7.68 crore in Q1FY26. Revenue from operations increased 17.8% year-on-year to ₹126.20 crore from ₹107.11 crore. Total income rose to ₹128.23 crore, compared with ₹108.67 crore in the year-ago quarter. Other income also increased, reaching ₹2.03 crore from ₹1.56 crore.

Profitability improved faster than costs

The quarter showed operating leverage, with profit before tax rising faster than expenses. Profit before tax increased 54.5% to ₹17.16 crore in Q1FY27, up from ₹11.11 crore in Q1FY26. Total expenses rose 13.8% to ₹111.07 crore, compared with ₹97.56 crore a year earlier. The gap between income growth and expense growth helped lift the bottom line. The company highlighted that profit before tax grew faster than expenses, pointing to improved cost absorption during the quarter.

Board approval and audit review status

The board of directors approved the unaudited financial results at its meeting on August 3, 2026, in Kolkata. The approval was subject to a limited review by the statutory auditors. S.R. Batliboi & Co. LLP issued an unmodified review conclusion. The conclusion was issued pursuant to Regulation 33 of the SEBI LODR Regulations, 2015, as disclosed in the update.

Earnings call scheduled: date, time, access

GPT Healthcare said it will host an earnings call on August 4, 2026, to discuss the unaudited Q1FY27 results for the quarter ended June 30, 2026. The session is scheduled to start at 11:00 AM IST and will be led by Group CFO Atul Tantia and other senior executives. The company also shared dial-in details for domestic and overseas participants and said participants can join after pre-registration.

Financial highlights table (normalized to ₹ crore)

Earnings call details

Additional market snapshot points mentioned

The update also described GPT Healthcare as a Kolkata-based hospital operator and referred to improvements in operations and patient volume recovery across its regional hospital network. It additionally noted that Q1FY27 net profit was slightly lower sequentially than the ₹14.57 crore recorded in Q4 FY26, based on the figures cited. Separately, the text referenced a market snapshot with shares trading at ₹157 and a market capitalisation of ₹1,281 crore, while noting P/E as “not meaningful”. It also carried a 12-month target range of ₹158-178 described as a “Uniresearch estimate”, alongside a note urging readers to cross-check figures with NSE/BSE filings.

Why this quarter matters for investors tracking hospital operators

The quarter’s key signal is the combination of higher revenue and a faster rise in profit before tax relative to expenses, which typically reflects better utilisation and improved operating leverage. The auditors’ unmodified limited review conclusion and the scheduled earnings call provide investors and analysts a clear channel to assess management commentary and the drivers behind the quarter’s performance. With the company explicitly positioning the earnings call as a forum for discussing results and taking stakeholder questions, attention is likely to remain on operating metrics and cost trends discussed during the call.

Conclusion

GPT Healthcare’s Q1FY27 results showed a year-on-year jump in net profit to ₹12.73 crore on operating revenue of ₹126.20 crore, alongside higher total income and a slower pace of expense growth. The unaudited results were approved by the board on August 3, 2026, and received an unmodified conclusion from the statutory auditors following a limited review. The next confirmed event is the earnings call scheduled for August 4, 2026 at 11:00 AM IST, where the company’s leadership, including Group CFO Atul Tantia, is expected to discuss the quarter’s performance.